Healthcare – Sanofi begins tender offer for Synthorx buy-out, Regeneron’s Ebola treatment gets orphan status Dec 23, 2019 Life Science
Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines Dec 20, 2019 Life Science
Healthcare Roundup – J&J acquires Taris Biomedical, Gilead’s Vosevi OK’d in China Dec 20, 2019 Life Science
Healthcare Roundup – Amgen files U.S. application for Rituxan biosimilar, Gilead files U.S. application for filgotinib Dec 19, 2019 Life Science
China’s Fosun, US’s Kite to Start Making Pioneering Lymphoma Drug in Shanghai Dec 19, 2019 Life Science
Healthcare Roundup – White House releases plan, Illumina to pay up to $34M to extend offer for Pacific Bio Dec 18, 2019 Life Science
Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody Dec 18, 2019 Life Science
Healthcare Roundup – Merck adds to aquaculture portfolio, CytoDyn out-licenses U.S. rights to leronlimab for HIV Dec 17, 2019 Life Science
Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million Dec 17, 2019 Life Science
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure Dec 17, 2019 Life Science
Healthcare Roundup – U.S. approves Roche-Spark merger, Ad Com Tuesday for AstraZeneca’s Lynparza for maintenance of pancreatic cancer Dec 16, 2019 Life Science
Healthcare Roundup – Eagle Pharma on go to launch Alimta alternative，FDA clears Boston Scientific single-use duodenoscope Dec 13, 2019 Life Science
United Imaging’s Artificial Intelligence Subsidiary Wins in Facebook AI Research & NYU School of Medicine Global Competition Dec 13, 2019 Life Science
Healthcare Roundup – House passes drug pricing bill, Roche and Fortelinea to co-market software solutions Dec 12, 2019 Life Science
CStone completes registration filing for the Phase I trial of its tumor immune microenvironment modulator CS3005 to enable study initiation in Australia Dec 12, 2019 Life Science
Zhejiang Medicine and Ambrx Present Positive Top Line Data from a Phase 1a/1b Clinical Trial of ARX788 in Metastatic HER2 Positive Breast Cancer Dec 12, 2019 Life Science
